John Baker isn’t convinced by the findings of a systematic review on smoking bans and violence in mental health settings, which concludes that the introduction of smoke-free policies generally do not lead to an increase in violence.
[read the full story...]
Olivia Maynard reports on a new study in The Lancet Psychiatry that explores the effect of implementing a smoke-free policy on physical violence in a psychiatric inpatient setting, which has some surprising findings.
[read the full story...]
Paul Christiansen presents the results of the EAGLES RCT into the neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patches in smokers with and without psychiatric disorders.
[read the full story...]
Andrew Jones reports on an ecological pragmatic clinical trial, which suggests that it is feasible to support smoking cessation in people with severe mental disorders such as bipolar disorder and schizophrenia.
[read the full story...]
Olivia Maynard summarises a recent Cochrane systematic review about the impact of institutional smoking bans on reducing harms and secondhand smoke exposure in hospitals, universities and prisons.
[read the full story...]
Andrew Jones reports on a recent systematic review and network meta-analysis of the efficacy and tolerability of pharmacotherapy for smoking cessation in severe mental illness, which finds a promising but low quality result for bupropion and varenicline.
[read the full story...]
Debutant blogger and vaping activist Lorien Jollye presents a new tobacco harm reduction report from the Tobacco Advisory Group of the Royal College of Physicians.
[read the full story...]
Olivia Maynard explores a recent systematic review that claims to be the first study to investigate systematically
the rates of restarting smoking after childbirth.
This review of smoking cessation for patients with head and neck cancer included 8 studies ( 3 RCTs) and suggests that those receiving counseling had a 26% higher quit rate than with controls
[read the full story...]
Paul Christiansen considers the findings of a recent RCT, which evaluates the effects of nicotine patches versus varenicline versus combination nicotine replacement therapy on smoking cessation at 26 weeks.
[read the full story...]
